Ceftazidime-Avibactam in Different Patient Populations
APR 26, 2017 | CONTAGION® EDITORIAL STAFF
Madeline King, PharmD, assistant professor of Clinical Pharmacy at the University of the Sciences, Philadelphia College of Pharmacy in Philadelphia, Pennsylvania, explains how her future research aims to understand the effects of ceftazidime-avibactam in different patient populations.
Interview Transcript (slightly modified for readability)
“I’m actually continuing to collect data from the hospital I was at, as well as the other 8 hospitals that were involved in this study to try and get as many patients into the study as possible. Again, it’s retrospective, so we’re going back a few months and saying, ‘okay, what patients received this in the past few months?’ [and analyzing that]. We’re not doing any prospective collection at this point.
What I will be trying to evaluate as I delve further into the research that I did [the effects of treatments on] patients who received ceftazidime-avibactam by itself versus with other agents. [I will evaluate] if that made a difference in mortality or clinical success or microbiologic success, (because I think that will be important going forward). [We’ll also] just [be] seeing what patients that it worked with, kind of trying to tease out [how treatment effected] patients who were in the ICU [Intensive Care Unit] or not in the ICU, patient who were immunocompromised versus not. What patients it worked well in, and if we can come up with any recommendations based on that.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Big advances in treatment can't make up for an inability to stop new infections, which number 5,000 per day worldwide.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512